Cargando…
Thyroid and renal cancers: A bidirectional association
There is a deep interrelation between the thyroid gland and the kidney parenchyma, with dysfunction of the first leading to significant changes in renal metabolism and vice versa. Given the recognition of cancer as a systemic disease, the raise of thyroid tumors and the common association of several...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538481/ https://www.ncbi.nlm.nih.gov/pubmed/36212468 http://dx.doi.org/10.3389/fonc.2022.951976 |
_version_ | 1784803355400339456 |
---|---|
author | Bellini, Maria Irene Lori, Eleonora Forte, Flavio Lauro, Augusto Tripodi, Domenico Amabile, Maria Ida Cantisani, Vito Varanese, Marzia Ferent, Iulia Catalina Baldini, Enke Ulisse, Salvatore D’Andrea, Vito Pironi, Daniele Sorrenti, Salvatore |
author_facet | Bellini, Maria Irene Lori, Eleonora Forte, Flavio Lauro, Augusto Tripodi, Domenico Amabile, Maria Ida Cantisani, Vito Varanese, Marzia Ferent, Iulia Catalina Baldini, Enke Ulisse, Salvatore D’Andrea, Vito Pironi, Daniele Sorrenti, Salvatore |
author_sort | Bellini, Maria Irene |
collection | PubMed |
description | There is a deep interrelation between the thyroid gland and the kidney parenchyma, with dysfunction of the first leading to significant changes in renal metabolism and vice versa. Given the recognition of cancer as a systemic disease, the raise of thyroid tumors and the common association of several malignancies, such as breast cancer, prostate cancer, colorectal cancer, and other, with an increased risk of kidney disease, public health alert for these conditions is warranted. A systematic review of the current evidence on the bidirectional relationship between thyroid and renal cancers was conducted including 18 studies, highlighting patient’s characteristics, histology, time for secondary malignancy to develop from the first diagnosis, treatment, and follow-up. A total of 776 patients were identified; median age was 64 years (range: 7–76 years). Obesity and family history were identified as the most common risk factors, and genetic susceptibility was suggested with a potential strong association with Cowden syndrome. Controversy on chemo and radiotherapy effects was found, as not all patients were previously exposed to these treatments. Men were more likely to develop kidney cancer after a primary thyroid malignancy, with 423/776 (54%) experiencing renal disease secondarily. Median time after the first malignancy was 5.2 years (range: 0–20 years). With the advancement of current oncological therapy, the prognosis for thyroid cancer patients has improved, although there has been a corresponding rise in the incidence of multiple secondary malignancy within the same population, particularly concerning the kidney. Surgery can achieve disease-free survival, if surveillance follow-up allows for an early localized form, where radical treatment is recommended. |
format | Online Article Text |
id | pubmed-9538481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95384812022-10-08 Thyroid and renal cancers: A bidirectional association Bellini, Maria Irene Lori, Eleonora Forte, Flavio Lauro, Augusto Tripodi, Domenico Amabile, Maria Ida Cantisani, Vito Varanese, Marzia Ferent, Iulia Catalina Baldini, Enke Ulisse, Salvatore D’Andrea, Vito Pironi, Daniele Sorrenti, Salvatore Front Oncol Oncology There is a deep interrelation between the thyroid gland and the kidney parenchyma, with dysfunction of the first leading to significant changes in renal metabolism and vice versa. Given the recognition of cancer as a systemic disease, the raise of thyroid tumors and the common association of several malignancies, such as breast cancer, prostate cancer, colorectal cancer, and other, with an increased risk of kidney disease, public health alert for these conditions is warranted. A systematic review of the current evidence on the bidirectional relationship between thyroid and renal cancers was conducted including 18 studies, highlighting patient’s characteristics, histology, time for secondary malignancy to develop from the first diagnosis, treatment, and follow-up. A total of 776 patients were identified; median age was 64 years (range: 7–76 years). Obesity and family history were identified as the most common risk factors, and genetic susceptibility was suggested with a potential strong association with Cowden syndrome. Controversy on chemo and radiotherapy effects was found, as not all patients were previously exposed to these treatments. Men were more likely to develop kidney cancer after a primary thyroid malignancy, with 423/776 (54%) experiencing renal disease secondarily. Median time after the first malignancy was 5.2 years (range: 0–20 years). With the advancement of current oncological therapy, the prognosis for thyroid cancer patients has improved, although there has been a corresponding rise in the incidence of multiple secondary malignancy within the same population, particularly concerning the kidney. Surgery can achieve disease-free survival, if surveillance follow-up allows for an early localized form, where radical treatment is recommended. Frontiers Media S.A. 2022-09-23 /pmc/articles/PMC9538481/ /pubmed/36212468 http://dx.doi.org/10.3389/fonc.2022.951976 Text en Copyright © 2022 Bellini, Lori, Forte, Lauro, Tripodi, Amabile, Cantisani, Varanese, Ferent, Baldini, Ulisse, D’Andrea, Pironi and Sorrenti https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Bellini, Maria Irene Lori, Eleonora Forte, Flavio Lauro, Augusto Tripodi, Domenico Amabile, Maria Ida Cantisani, Vito Varanese, Marzia Ferent, Iulia Catalina Baldini, Enke Ulisse, Salvatore D’Andrea, Vito Pironi, Daniele Sorrenti, Salvatore Thyroid and renal cancers: A bidirectional association |
title | Thyroid and renal cancers: A bidirectional association |
title_full | Thyroid and renal cancers: A bidirectional association |
title_fullStr | Thyroid and renal cancers: A bidirectional association |
title_full_unstemmed | Thyroid and renal cancers: A bidirectional association |
title_short | Thyroid and renal cancers: A bidirectional association |
title_sort | thyroid and renal cancers: a bidirectional association |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538481/ https://www.ncbi.nlm.nih.gov/pubmed/36212468 http://dx.doi.org/10.3389/fonc.2022.951976 |
work_keys_str_mv | AT bellinimariairene thyroidandrenalcancersabidirectionalassociation AT lorieleonora thyroidandrenalcancersabidirectionalassociation AT forteflavio thyroidandrenalcancersabidirectionalassociation AT lauroaugusto thyroidandrenalcancersabidirectionalassociation AT tripodidomenico thyroidandrenalcancersabidirectionalassociation AT amabilemariaida thyroidandrenalcancersabidirectionalassociation AT cantisanivito thyroidandrenalcancersabidirectionalassociation AT varanesemarzia thyroidandrenalcancersabidirectionalassociation AT ferentiuliacatalina thyroidandrenalcancersabidirectionalassociation AT baldinienke thyroidandrenalcancersabidirectionalassociation AT ulissesalvatore thyroidandrenalcancersabidirectionalassociation AT dandreavito thyroidandrenalcancersabidirectionalassociation AT pironidaniele thyroidandrenalcancersabidirectionalassociation AT sorrentisalvatore thyroidandrenalcancersabidirectionalassociation |